IFIH1 and clinically amyopathic dermatomyositis: In a retrospective analysis of 13 patients with anti-MDA5 Abs-positive cADM, Takada et al. [15] reported that mortality was associated with high levels of anti-MDA5 Abs, suggesting that the levels of anti-MDA5 Abs could be useful in predicting prognosis.